These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23249183)

  • 1. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
    Mosawy S; Jackson DE; Woodman OL; Linden MD
    Platelets; 2013; 24(8):594-604. PubMed ID: 23249183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes.
    Mosawy S; Jackson DE; Woodman OL; Linden MD
    Diab Vasc Dis Res; 2014 May; 11(3):174-81. PubMed ID: 24623318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.
    Mosawy S; Jackson DE; Woodman OL; Linden MD
    J Thromb Thrombolysis; 2013 Jul; 36(1):50-7. PubMed ID: 23070586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute bilirubin ditaurate exposure attenuates ex vivo platelet reactive oxygen species production, granule exocytosis and activation.
    Pennell EN; Wagner KH; Mosawy S; Bulmer AC
    Redox Biol; 2019 Sep; 26():101250. PubMed ID: 31226648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular and anti-oxidant actions of flavonols and flavones.
    Woodman OL; Chan ECh
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):786-90. PubMed ID: 15566394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro.
    Xiang K; Liu G; Zhou YJ; Hao HZ; Yin Z; He AD; Da XW; Xiang JZ; Wang JL; Ming ZY
    Thromb Res; 2014 Feb; 133(2):211-7. PubMed ID: 24332167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
    Sim DS; Dilks JR; Flaumenhaft R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
    Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice.
    Grambow E; Mueller-Graf F; Delyagina E; Frank M; Kuhla A; Vollmar B
    Platelets; 2014; 25(3):166-74. PubMed ID: 23586391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K; Rothe G; Schmitz G
    Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z; Théroux P; Frojmovic M
    Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression.
    Faraday N; Rosenfeld BA
    Anesthesiology; 1998 Jun; 88(6):1579-85. PubMed ID: 9637652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
    Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
    Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
    Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.